Dendreon Corp. (NASDAQ DNDN)
After Hours: 7.84
0.52 (7.10%) as of 6:10PM ETDendreon Corp. is breaking through both the 50 and 200 day moving averages in after hours trading.
DNDN is attracting buyers after a report indicated that Dendreon's vaccine Neuvenge "appears to be safe in women with advanced breast cancer and showed signs of actually slowing down tumors".
Labels: bio tech investing, biotech, biotech mill rumor, biotech stocks, Dendreon
posted by doublezero at
3:24 PM
1 Comments:
Hindalco Q3 profit up 7.5% to Rs 359 cr, misses forecast. nifty option tips
Post a Comment
Subscribe to Post Comments [Atom]
<< Home